Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Archives of Cardiovascular Diseases|January 12, 2019
Percutaneous coronary interventions with the Absorb Bioresorbable vascular scaffold in real life: 1-year results from the FRANCE ABSORB registryGuillaume Cayla, René Koning, Jean Fajadet, et al.
Catheterization and Cardiovascular Interventions : Official Journal of the Society for Cardiac Angiography & Interventions|June 30, 2012
Ambulatory transradial percutaneous coronary intervention: a safe, effective, and cost-saving strategyPhilippe Le Corvoisier, Barnabas Gellen, Pierre-François Lesault, et al.
International Journal of Cardiology|February 7, 2018
Systematic detection of polyvascular disease combined with aggressive secondary prevention in patients presenting with severe coronary artery disease: The randomized AMERICA StudyJean-Philippe Collet, Guillaume Cayla, Pierre-Vladimir Ennezat, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 7, 2022
Watchman FLX vs. Watchman 2.5 in a Dual-Center Left Atrial Appendage Closure Cohort: the WATCH-DUAL studyRoberto Galea, Khalil Mahmoudi, Christoph Gräni, et al.
Circulation. Cardiovascular Interventions|November 8, 2019
Reasons for the Failure of Platelet Function Testing to Adjust Antiplatelet Therapy: Pharmacodynamic Insights From the ARCTIC StudyBenoit Lattuca, Johanne Silvain, Yan Yan, et al.
International Journal of Cardiology|February 26, 2020
Strain predicts left ventricular functional recovery after acute myocardial infarction with systolic dysfunctionAhmed Ben Driss, Caroline Ben Driss Lepage, Anis Sfaxi, et al.
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|November 15, 2016
Safety and efficacy of a bioabsorbable polymer-coated, everolimus-eluting coronary stent in patients with diabetes: the EVOLVE II diabetes substudyDean J Kereiakes, Ian T Meredith, Monica Masotti, et al.
European Journal of Clinical Pharmacology|August 13, 2015
Genetic and platelet function testing of antiplatelet therapy for percutaneous coronary intervention: the ARCTIC-GENE studyJean-Philippe Collet, Jean-Sébastien Hulot, Thomas Cuisset, et al.
The American Journal of Cardiology|September 10, 2013
A direct comparison of intravenous enoxaparin with unfractionated heparin in primary percutaneous coronary intervention (from the ATOLL trial)Jean-Philippe Collet, Kurt Huber, Marc Cohen, et al.
American Heart Journal|December 3, 2014
Platelet function monitoring in elderly patients on prasugrel after stenting for an acute coronary syndrome: design of the randomized antarctic studyGuillaume Cayla, Thomas Cuisset, Johanne Silvain, et al.
Pageof 4